Brain Age Modeling for Post-Stroke Cognitive Decline Prediction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assessing cognitive decline due to ischemic stroke, such as the Clinical Dementia Rating (CDR), are limited in their ability to predict future outcomes and are heavily reliant on clinician judgment and informant reliability, and diffusion MRI data are impaired by susceptibility-induced distortions, affecting the accuracy of dementia progression prediction.
Innovation Solution
A method using white matter brain age score (WM PAD) derived from diffusion tensor imaging (DTI) data, corrected for artifacts, to predict the severity and future change in CDR, and a brain age model to evaluate therapeutic effects on cognitive impairment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If clinical dementia rating (CDR) interview is used to assess cognitive status, then cognitive severity can be graded, but future dementia progression cannot be predicted
Solution Approach 1:
The patent applies preliminary action by using baseline diffusion MRI data and brain age prediction models to forecast future dementia progression before it occurs. The system processes initial imaging data to generate predictive metrics that anticipate cognitive decline trajectories, enabling early intervention planning.
Solution Approach 2:
The patent introduces diffusion MRI-derived metrics and brain age models as intermediary indicators between current cognitive status and future dementia outcomes. These intermediate biomarkers serve as predictive bridges, translating static clinical assessments into dynamic progression forecasts.
2Reliability
If CDR interview is conducted by certified physicians, then reliable dementia staging is achieved, but clinician judgment and informant reliability limitations persist
Solution Approach 1:
The patent replaces the mechanical system of human clinical assessment with automated image analysis algorithms and machine learning models. Diffusion MRI data processing and brain age prediction systems substitute for clinician judgment, eliminating variability in human assessment while maintaining diagnostic accuracy.
Solution Approach 2:
The patent creates objective digital copies of cognitive status through quantitative imaging metrics and predictive models. Instead of relying on subjective clinical interviews, the system generates reproducible numerical representations of brain structure and function that can be consistently analyzed without human involvement.
3Quantity of substance
If diffusion MRI data is used for dementia prediction, then structural brain information is obtained, but susceptibility-induced distortions reduce accuracy
Solution Approach 1:
The patent converts the harmful susceptibility-induced distortions in diffusion MRI data into beneficial information by using them as features for brain age prediction. Instead of attempting to completely eliminate these distortions, the system leverages them as characteristic patterns that correlate with cognitive aging and dementia risk.
Solution Approach 2:
The patent changes the analytical parameters by transforming raw diffusion MRI measurements into derived metrics such as fractional anisotropy, mean diffusivity, and brain age estimates. These parameter transformations convert problematic raw data with distortions into robust predictive features that are less sensitive to acquisition artifacts.
Data Source
AI summary
A method of predicting an effect of ischemic stroke on an individual's cognitive status comprises (1) acquiring at least one medical brain image of an individual's brain after the ischemic stroke of the individual; (2) processing the medical brain image to obtain at least one feature of the image; (3) generating a gray matter brain age (GMBA) value of the individual based on the at least one feature of the image; and (4) predicting an effect of the ischemic stroke on the individual's post-stroke cognitive status (PSCI) using the GMBA value.